ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?

Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. · 2019

Read ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? by Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6909825.txt.

Description

Mejzini and co-authors review ALS genetics and treatment, in Frontiers in Neuroscience. Amyotrophic lateral sclerosis destroys the motor neurons that move muscles. Its causes remain largely unexplained despite decades of work. More than 50 genes have now been tied to risk or to the disease process itself. Yet most patients still have few treatment options.

The review walks through the most commonly mutated genes and how each may injure neurons. It also asks why so much of the inheritance stays hidden, pointing to gene-environment interplay and patient subgroups. Several cellular processes recur across genetic forms, from protein clumping to faulty RNA handling. Sorting patients by subtype, the authors argue, is the path to personalised therapy.

Catalog record

CREATORMejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE161 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6909825

Browse the full library · About the Tower of Babel